This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,608.44 firm fixed-price delivery order covers the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a specialty pharmaceutical product.
The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a comprehensive contracting vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, which runs through November 2026, enables efficient government procurement of essential medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas.
The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen, as the prime contractor, plays a critical role in supplying medical products to various federal government agencies, particularly within the military and veterans' healthcare systems.
Generated 3/23/25, 1:02 AM